Methods of treatment using selective 5-HT2A inverse agonists
US9765053B2 · kind B2 · utility
12Cited by
42References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 21, 2011 |
| Grant date | Sep 19, 2017 |
| Priority date | — |
| Expiry date | Aug 10, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D487/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds and methods are provided for the treatment of disease conditions in which modification of serotonergic receptor activity has a beneficial effect. In the method, an effective amount of a compound is administered to a patient in need of such treatment.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.